CX DAILY

CX Daily: China’s Rock Bottom Drug Prices Spark Quality Concerns

Published: Feb. 6, 2025 9:53 a.m. GMT+8

00:00

00:00/00:00

Listen to this article 1x

Drug /

Analysis: China’s rock bottom drug prices spark quality concerns

In a bid to lower the prices the Chinese state and public pay for medicines, Beijing implemented its centralized procurement policy in 2018. Under this system, the drugs are included by China’s state-run health care insurance and negotiated on a national basis.

Ever since, it has been fiercely debated whether or not the hard bargains driven by the government undermine the quality of the drugs.

Unlock exclusive discounts with a Caixin group subscription — ideal for teams and organizations.

Subscribe to both Caixin Global and The Wall Street Journal — for the price of one.

Share this article

Open WeChat and scan the QR code

GALLERY

: Gallery: Powerful Quake Strikes Off Japan

NEWSLETTERS

Get our CX Daily, weekly Must-Read and China Green Bulletin newsletters delivered free to your inbox, bringing you China's top headlines.

We ‘ve added you to our subscriber list.

Manage subscription

PODCAST

Caixin Deep Dive: Chinese Local Governments Risk Replicating Mistakes of LGFVs

00:00

00:00/00:00

MOST POPULAR

1: PDD Fires Government Relations Staff After Fistfight With Regulators

2: China Ramps Up Effort to Offload Vast Supply of Unsold Homes

3: China’s Elite-Focused Schools Are Failing Most Students, Top Educators Say

4: In Depth: China’s Developers Try to Modernize After Surge in Subpar Homes

5: Cover Story: Trading by Algorithm: Who is Responsible When AI Calls the Shots?